Repros Therapeutics, Inc. (RPRX)

[spartex]

Charmed, from your summary of discussion with management, I'm wondering what this will do in terms of the cash needs of RPRX as it relates to covering costs of Androxal and Prollex trials in 2008 going forward? I wonder if they will still consider just selling the entire Androxal part of their company rather than work through all of these trials?

Thanks for your summary!